TY - JOUR
T1 - Circulating angiotensin II and dietary salt
T2 - Converging signals for neurogenic hypertension
AU - Osborn, John W.
AU - Fink, Gregory D.
AU - Sved, Alan F.
AU - Toney, Glenn M.
AU - Raizada, Mohan K.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/6
Y1 - 2007/6
N2 - Circulating angiotensin II (Ang II) combined with high salt intake increases sympathetic nerve activity (SNA) in some forms of hypertension. Ang II-induced increases in SNA are modest, delayed, and specific to certain vascular beds. The brain targets for circulating Ang II are neurons in the area postrema (AP), subfornical organ (SFO), and possibly other circumventricular organs, Ang II signaling is integrated with sodium-sensitive neurons in the SFO and/or organum vasculosum of the lamina terminalis (OVLT) and drives sympathetic premotor neurons in the rostral ventrolateral medulla (RVLM) via the paraventricular nucleus (PVN). It is likely that, over time, new patterns of gene expression emerge within neurons of the SFO-PVN-RVLM pathway that transform their signaling properties. This transformation is critical in maintaining increased SNA. Identification of a novel gene supporting this process may provide new targets for treatment of neurogenic hypertension.
AB - Circulating angiotensin II (Ang II) combined with high salt intake increases sympathetic nerve activity (SNA) in some forms of hypertension. Ang II-induced increases in SNA are modest, delayed, and specific to certain vascular beds. The brain targets for circulating Ang II are neurons in the area postrema (AP), subfornical organ (SFO), and possibly other circumventricular organs, Ang II signaling is integrated with sodium-sensitive neurons in the SFO and/or organum vasculosum of the lamina terminalis (OVLT) and drives sympathetic premotor neurons in the rostral ventrolateral medulla (RVLM) via the paraventricular nucleus (PVN). It is likely that, over time, new patterns of gene expression emerge within neurons of the SFO-PVN-RVLM pathway that transform their signaling properties. This transformation is critical in maintaining increased SNA. Identification of a novel gene supporting this process may provide new targets for treatment of neurogenic hypertension.
UR - http://www.scopus.com/inward/record.url?scp=34250217818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250217818&partnerID=8YFLogxK
U2 - 10.1007/s11906-007-0041-3
DO - 10.1007/s11906-007-0041-3
M3 - Review article
C2 - 17519130
AN - SCOPUS:34250217818
SN - 1522-6417
VL - 9
SP - 228
EP - 235
JO - Current Hypertension Reports
JF - Current Hypertension Reports
IS - 3
ER -